Acibadem Healthcare Group
ZÜLEYHA AKKAN ÇETİNKAYA (M) (G)
Prof. M.D.

ZÜLEYHA AKKAN ÇETİNKAYA (M) (G)

Medical Units and Clinical Services
  • Gastroenterology

Education

  • 2019 Gelisim University / Professorship
  • 2013 Kocaeli Derince Training and Research Hospital / Associate Professorship
  • 2009 Haydarpasa Numune Training and Research Hospital Gastroenterology
  • 2003 Haydarpasa Numune Training and Research Hospital Internal Medicine
  • 1998 Istanbul University Faculty of Medicine

Experience

  • 2025 Acibadem Health Group
  • 2019 – 2025 Memorial Ataşehir Hospital / Gastroenterology / Professor
  • 2014 – 2019 Medical Park Gebze Hospital ,Bahçeşehir University Faculty of Medicine / Gastroenterology / Associate Professor
  • 2013 – 2014 Kocaeli Derince Training and Research Hospital / Gastroenterology / Associate Professor
  • 2009 – 2013 Kocaeli Derince Training and Research Hospital / Gastroenterology Specialist
  • 2003 – 2009 Haydarpaşa Numune Training and Research Hospital Gastroenterology Clinic / Subspecialty Assistant
  • 1998 – 2003 Haydarpaşa Numune Training and Research Hospital 1st Internal Medicine Clinic / Assistant Dr.

Memberships

  • Gastrointestinal Endoscopy Society
  • Turkish Gastroenterology Association
  • Turkish Association for Liver Research
  • Inflammatory Bowel Diseases Association

Publications

  • Being a female gastroenterologist in Turkey,
    Turkish Journal of Gastroenterol 2024 Z. Akkan Çetinkaya, N. Tözün, Ö. Ersoy .
  • In Vitro Effects of Vitamins C and E on Helicobacter pylori,
    Mol Virol Immunol 2021 M. Kaya, A Tanoğlu, Z. Akkan Çetinkaya, E. S. Boz, H. Sezikli, F. Güzelbulut, M. Sezikli
  • The value of adenosine deaminase level in assesing activation of inflammatory bowel disease
    Journal of Surgery and Medicine, 2020. Y. Gökden, S Hot, C. Gönen, S Kalyon, Z. Akkan Çetinkaya.
  • Comparison of the efficacy of six different Helicobacter pylori eradication regimens: greater than or equal to another
    Biomedical Research 2018 M. Sezikli, G Sirin, Z A Cetinkaya et al
  • A lower serum gamma-glutamyltransferase level does not predict a sustained virological response in patients with chronic hepatitis C genotype 1
    Gut and Liver 2013. F Guzelbulut, M Sezikli, ZA Cetinkaya et al
  • Evaluation of colorectal adenocarcinomas at single institution with respect to microsatellite instability,
    Chirurgia ,2013 Ozkara,B.Sari,A.Yesil,A. Aktekin,M.Sezikli,Z. Cetinkaya,F.Aker
  • AST-platelet ratio index (APRI) in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
    Turkish Journal of Gastroenterology , 2012 F.Güzelbulut,M.Sezikli, Z.Akkan Çetinkaya,B Yaşar, S. Özkara, A.O.K Övünç,
  • Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B
    Hepatogastroenterology 2012 F. Guzelbulut, A.Okurdaş Ovünç,Z.Akkan Çetinkaya, E. Şenateş, Y.Gökden, A.G.Değirmenci Saltürk, M.Sezikli, S.Özkara, F.Çetinkaya
  • Efficacy of the combination of tetracycline ,amoxicillin and lansoprazole in the eradication of helicobacter pylori in treatment naive patients and in
    Gut and Liver, 2012 M.Sezikli, Z.Akkan Çetinkaya,F.Güzelbulut, A.Yeşil, M.E.Altunöz, N.Ulu, AOO Kurdaş,
  • Metabolic syndrome in inflammatory bowel disease. A real relationship or just coincidence.
    Euroasian Journal of Hepato-Gastroenterology, 2012 Sezikli , Z. Akkan Çetinkaya, F. Güzelbulut, D. Özgil Yetkin




×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Health Library
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics